G Marenco

1.1k total citations
21 papers, 663 citations indexed

About

G Marenco is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, G Marenco has authored 21 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Surgery and 7 papers in Hepatology. Recurrent topics in G Marenco's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (3 papers) and Systemic Lupus Erythematosus Research (3 papers). G Marenco is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (3 papers) and Systemic Lupus Erythematosus Research (3 papers). G Marenco collaborates with scholars based in Italy. G Marenco's co-authors include Francesco Salerno, Angelo Sangiovanni, M. Cazzaniga, Mauro Borzio, Stefania Boccia, Lucas Piantoni, Franco Bissoli, M. Salvagnini, Paolo Angeli and Gino Fornaciari and has published in prestigious journals such as Journal of Hepatology, Alimentary Pharmacology & Therapeutics and Clinical Gastroenterology and Hepatology.

In The Last Decade

G Marenco

21 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Marenco Italy 9 356 333 299 108 76 21 663
Edward Lebovics United States 16 431 1.2× 464 1.4× 238 0.8× 105 1.0× 43 0.6× 68 837
Jan Freeman United Kingdom 18 374 1.1× 371 1.1× 455 1.5× 205 1.9× 74 1.0× 36 872
N. Terreni Italy 11 600 1.7× 519 1.6× 375 1.3× 103 1.0× 119 1.6× 19 938
Thomas Shaw‐Stiffel United States 11 383 1.1× 278 0.8× 255 0.9× 54 0.5× 18 0.2× 21 633
Fred A. Simmons United States 13 174 0.5× 298 0.9× 297 1.0× 89 0.8× 17 0.2× 24 769
Prabha Sawant India 15 194 0.5× 267 0.8× 303 1.0× 84 0.8× 119 1.6× 70 651
Neil Rajoriya United Kingdom 14 586 1.6× 480 1.4× 340 1.1× 65 0.6× 32 0.4× 44 854
Mireia Miquel Spain 15 594 1.7× 555 1.7× 283 0.9× 105 1.0× 43 0.6× 60 882
K. Haag Germany 17 772 2.2× 610 1.8× 707 2.4× 149 1.4× 49 0.6× 43 1.1k
Tsung‐Hsing Hung Taiwan 15 350 1.0× 328 1.0× 226 0.8× 113 1.0× 65 0.9× 57 630

Countries citing papers authored by G Marenco

Since Specialization
Citations

This map shows the geographic impact of G Marenco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Marenco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Marenco more than expected).

Fields of papers citing papers by G Marenco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Marenco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Marenco. The network helps show where G Marenco may publish in the future.

Co-authorship network of co-authors of G Marenco

This figure shows the co-authorship network connecting the top 25 collaborators of G Marenco. A scholar is included among the top collaborators of G Marenco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Marenco. G Marenco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Andriulli, Angelo, L. Solmi, Silvano Loperfido, et al.. (2004). Prophylaxis of ERCP-related pancreatitis: A randomized, controlled trial of somatostatin and gabexate mesylate. Clinical Gastroenterology and Hepatology. 2(8). 713–718. 84 indexed citations
3.
Stella, Marco, Michele Minuto, M Pasqualini, et al.. (2003). [Intraoperative use of radiofrequency thermoablation of liver tumors: considerations on indications and related therapeutic aspects].. PubMed. 73(5). 511–6; discussion 517. 5 indexed citations
4.
Borzio, Mauro, Francesco Salerno, Lucas Piantoni, et al.. (2001). Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Digestive and Liver Disease. 33(1). 41–48. 334 indexed citations
5.
Picciotto, A., R. Brizzolara, Nicoletta Sinelli, et al.. (1999). Interferon retreatment in chronic hepatitis C. European Journal of Gastroenterology & Hepatology. 11(6). 649–654. 2 indexed citations
6.
Pellicano, Rinaldo, Riccardo Bigi, Maria Teresa La Rovere, et al.. (1999). Patients with acute myocardial infarction in northern Italy are often infected by Helicobacter pylori.. PubMed. 41(4). 279–82. 11 indexed citations
7.
Salerno, Francesco, Pamela Moser, Angelo Sangiovanni, et al.. (1996). Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. Journal of Hepatology. 25(4). 474–480. 39 indexed citations
8.
Menotti, A, Fulvia Seccareccia, Mariapaola Lanti, et al.. (1995). Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970's and the 1980's. The Italian RIFLE Pooling Project. Risk factors and life expectancy.. PubMed. 25(12). 1539–72. 24 indexed citations
9.
Picciotto, A., Francesco Callea, Veronica Conca, et al.. (1995). Lymphoblastoid interferon therapy in chronic hepatitis C: biochemical, virological and histological evaluation of two different doses. Liver International. 15(1). 20–24. 16 indexed citations
10.
Rainisio, Maurizio, et al.. (1992). [Therapy of chronic non-A, non-B hepatitis with interferon alfa-2B. A controlled clinical study and long-term follow-up].. PubMed. 37(2). 85–90. 5 indexed citations
11.
Contu, A., G Marenco, P. Pani, et al.. (1990). [Preventive role of pirenzepine in gastric damage during cytostatic therapy. A controlled randomized double-blind study with placebo].. PubMed. 35(4). 269–72. 1 indexed citations
12.
Pretis, G. De, G Dobrilla, Andrea Ferrari, et al.. (1989). Comparison between single morning and bedtime doses of 40 mg famotidine for the treatment of duodenal ulcer. Alimentary Pharmacology & Therapeutics. 3(3). 285–291. 9 indexed citations
13.
Valenti, S. & G Marenco. (1989). Italian Multicenter Study on the Treatment of Chronic Obstructive Lung Disease with Bromhexine. Respiration. 56(1-2). 11–15. 8 indexed citations
14.
Tarantino, Vincenzo, et al.. (1988). [Advantages of treatment with bromhexine in acute sinus inflammation in children. Randomized double-blind study versus placebo].. PubMed. 40(11). 649–52. 4 indexed citations
15.
Dobrilla, G, G. De Pretis, Luigi Piazzi, et al.. (1987). Comparison of Once-Daily Bedtime Administration of Famotidine and Ranitidine in the Short-Term Treatment of Duodenal Ulcer a Multicenter, Double-Blind, Controlled Study. Scandinavian Journal of Gastroenterology. 22(sup134). 21–28. 14 indexed citations
16.
Bausano, G, et al.. (1987). Large-bowel transit in paraplegic patients. Diseases of the Colon & Rectum. 30(12). 924–928. 95 indexed citations
17.
Marenco, G, et al.. (1981). [The importance of thyroid hormone determination in the course of acute and chronic liver diseases].. PubMed. 72(40). 2669–74. 1 indexed citations
18.
Cheli, R, Attilio Giacosa, G Marenco, et al.. (1981). Chronic gastritis and alcohol.. PubMed. 19(9). 459–63. 3 indexed citations
19.
Marenco, G, et al.. (1970). [Lactose intolerance in adults].. PubMed. 22(11). 505–13. 5 indexed citations
20.
Marenco, G, et al.. (1969). [Enteric protein loss studied with the use of polyvinylpyrrolidone-I-131 in peritonitis and in tuberculosis of the mesenteric lymph nodes].. PubMed. 15(2). 49–59. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026